Starting the Same SSRI Two Different Ways
Placeholder lead: one starting dose, two very different destinations ahead.
- 0.5x: Starting dose (placeholder: low starting dose)
- 1-2 wk: Titration interval (placeholder: dose review cadence)
- 1.0x: Depression ceiling (placeholder: standard max)
- 2-3x: OCD ceiling (placeholder: high-dose max)
Placeholder section heading
Placeholder body text: identical low starting dose for both conditions.
Placeholder highlight: paths diverge only after week one.
Placeholder heading two
Placeholder body text: baseline symptom severity assessed before titration.
Standard-Dose Titration for Depression
Placeholder lead: dose rises modestly, response arrives within weeks.
- 1.0x: Target dose (placeholder: standard therapeutic)
- wk 4-6: Response onset (placeholder: typical timeline)
- ~50%: Remission rate (placeholder: monotherapy)
- 1-2: Dose changes (placeholder: typical titration steps)
Placeholder section heading
Placeholder body text: dose reaches standard range by week four.
Placeholder highlight: earlier upswing than OCD path.
Placeholder heading two
Placeholder body text: response curve climbs steadily after onset.
High-Dose Titration for OCD
Placeholder lead: dose climbs well past the depression ceiling.
- 2-3x: Target dose (placeholder: high-dose ceiling)
- slower: Titration pace (placeholder: more steps upward)
- ongoing: Tolerability watch (placeholder: side-effect monitoring)
- 3-5: Dose changes (placeholder: typical titration steps)
Placeholder section heading
Placeholder body text: dose keeps rising past standard depression range.
Placeholder highlight: ceiling roughly 2-3x depression dose.
Placeholder heading two
Placeholder body text: higher receptor occupancy targeted for OCD circuits.
The Extended Response Timeline
Placeholder lead: improvement lags even after the dose ceiling is reached.
- wk 8-12: Response onset (placeholder: delayed vs depression)
- ≥10 wk: Trial length (placeholder: at max tolerated dose)
- after trial: Switch/augment (placeholder: only if inadequate)
- +4-6 wk: Gap vs depression (placeholder: extra wait time)
Placeholder section heading
Placeholder body text: full high-dose trial requires extended patience.
Placeholder highlight: premature switching risks abandoning efficacy.
Placeholder heading two
Placeholder body text: gradual response curve continues climbing late.
Side-by-Side: Dose Ceiling and Timeline
Placeholder lead: two protocols compared directly on one timeline.
- 1.0x: Depression ceiling (placeholder: standard dose)
- 2.5x: OCD ceiling (placeholder: high dose)
- wk 4-6: Depression response (placeholder: earlier onset)
- wk 8-12: OCD response (placeholder: delayed onset)
Placeholder section heading
Placeholder body text: same slider, two divergent curves shown together.
Placeholder highlight: OCD needs higher dose and more patience.
Placeholder heading two
Placeholder body text: clinical takeaway favors adequate trial length.